Clinicopathological and biological assessment of lung cancers with pleural dissemination Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.

Slides:

Advertisements

Similar presentations

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Advertisements

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Primary non-Hodgkin’s lymphoma of the lung

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi.

Outcomes of Reintervention on the Autograft After Ross Procedure

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Joshua E. Rosen, BASc, Hari B

Tumor marker expression is predictive of survival in patients with esophageal cancer Thomas A Aloia, MD, David H Harpole, MD, Carolyn E Reed, MD, Carmen.

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Lars P. Riber, MD, PhD, Thomas D. Christensen,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer Kyoji Hirai, MD, Kiyoshi Koizumi, MD, Shuji Haraguchi, MD,

Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma Masahiro Yasunaga,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,

Relationship between amount of lung resected and outcome after lung volume reduction surgery Matthew Brenner, MD, Robert J McKenna, MD, John C Chen,

Andrea S. Wolf, MD, MPH, Scott J

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non- small Cell Lung Cancer After Surgery Xianhua Xu, MD, Ping-Li Sun,

Lung Cancer Surgery in Patients With Liver Cirrhosis

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Clinicopathologic Features of Resected Subcentimeter Lung Cancer

Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma Shintaro Yokoyama, MD, Hiroaki Miyoshi, MD, PhD, Tatsuya.

Contributions of bronchoscopic microsampling in the supplemental diagnosis of small peripheral lung carcinoma Masazumi Watanabe, MD, PhD, Akitoshi Ishizaka,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy Eduard L Mutsaerts, MSc, Frans A Zoetmulder, MD, Sybren Meijer,

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.

A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions Hisao Asamura, MD, Kenji Suzuki,

Expression of vascular endothelial growth factor in thoracic sarcomas

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Henri Porte, MD, PhD, Joëlle Siat, MD, Benoit Guibert, MD, Francoise.

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Is there a role for pneumonectomy in pulmonary metastases?1

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer Bernward Passlick, MD, Boris Kubuschok, MD,

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Congenital absence of the right upper lobe of the lung

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Presentation transcript:

Clinicopathological and biological assessment of lung cancers with pleural dissemination Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto Oda, MD, Shun-ichi Watanabe, MD, Junzo Shimizu, MD, Yoh Watanabe, MD The Annals of Thoracic Surgery Volume 69, Issue 4, Pages 1025-1029 (April 2000) DOI: 10.1016/S0003-4975(99)01579-9

Fig 1 Kaplan-Meier survival plots for 43 lung cancer patients with pleural dissemination who underwent resection of the primary tumor plus parietal pleurectomy. The Annals of Thoracic Surgery 2000 69, 1025-1029DOI: (10.1016/S0003-4975(99)01579-9)

Fig 2 Kaplan-Meier survival plots for lung cancer patients with pleural dissemination stratified by operative procedures. The outcome of the patients who underwent pleuropneumonectomy was significantly worse than that of the patients with limited operations. The Annals of Thoracic Surgery 2000 69, 1025-1029DOI: (10.1016/S0003-4975(99)01579-9)

Fig 3 Examples of immunohistochemical staining for (A) VEGF and (B) AMFR/gp78. For VEGF, cytoplasmic staining was positive in tumor cells, and weak staining was also found in interstitial epithelial components. AMFR/gp78 antigen was mainly identified in the cell membrane and cytoplasm of tumor cells. The Annals of Thoracic Surgery 2000 69, 1025-1029DOI: (10.1016/S0003-4975(99)01579-9)